Lemaitre Vascular (LMAT) Total Current Liabilities (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Total Current Liabilities of $33.4 million for Q1 2026, up 34.85% year-over-year from $24.7 million in Q1 2025, and down 8.13% quarter-over-quarter from $36.3 million in Q4 2025.
Lemaitre Vascular (LMAT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Total Current Liabilities for 17 consecutive years, with $33.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 34.85% year-over-year to $33.4 million; the TTM figure through Mar 2026 stood at $33.4 million (up 34.85% YoY), while the FY2025 annual figure was $36.3 million, up 18.68% from the prior year.
- Total Current Liabilities slipped to $33.4 million in Q1 2026 per LMAT's latest filing, from $36.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $36.3 million in Q4 2025 and bottomed at $18.3 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $27.6 million across 5 years, with a median of $26.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities dropped 18.09% — and 2026, when it soared 34.85%.
- Lemaitre Vascular's Total Current Liabilities stood at $25.3 million in 2022, then gained by 17.96% to $29.9 million in 2023, then rose by 2.44% to $30.6 million in 2024, then advanced by 18.68% to $36.3 million in 2025, then retreated by 8.13% to $33.4 million in 2026.
- Business Quant data shows LMAT's Total Current Liabilities at $33.4 million in Q1 2026, $36.3 million in Q4 2025, and $33.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.49 Bn | 129.28 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.54 Bn | 51.67 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.71 Bn | 34.35 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.80 Bn | 32.33 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.08 Bn | 26.40 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.52 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.51 Bn | 50.76 Mn | 29.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.94 Mn |
| Mar 31, 2026 | 33.37 Mn |
| Dec 31, 2025 | 36.32 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 30.82 Mn |
| Mar 31, 2025 | 24.75 Mn |
| Dec 31, 2024 | 30.61 Mn |
| Sep 30, 2024 | 29.34 Mn |
| Jun 30, 2024 | 25.45 Mn |
| Mar 31, 2024 | 26.81 Mn |
| Dec 31, 2023 | 29.88 Mn |
| Sep 30, 2023 | 29.03 Mn |
| Jun 30, 2023 | 25.86 Mn |
| Mar 31, 2023 | 23.90 Mn |
| Dec 31, 2022 | 25.33 Mn |
| Sep 30, 2022 | 23.44 Mn |
| Jun 30, 2022 | 23.41 Mn |
| Mar 31, 2022 | 18.27 Mn |
| Dec 31, 2021 | 21.81 Mn |
| Sep 30, 2021 | 22.11 Mn |